Across TCGA pan-cancer cohorts, C6orf47 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated C6orf47 data layer compared with 25 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher C6orf47 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C6orf47 expression acts as an unfavorable survival marker.

LUSC, UCEC, and CHOL are the cancer types where C6orf47 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.168	0.675	.021	18	view →
UCEC	OS	Median	IV	0.066	0.755	<.001	12	view →
CHOL	OS	Median	All	0.155	0.725	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: C6orf47 tumor-vs-normal RNA expression · all C6orf47 data types